Arcturus Dividend Paid And Capex Coverage Ratio from 2010 to 2024

ARCT Stock  USD 17.95  0.41  2.23%   
Arcturus Therapeutics Dividend Paid And Capex Coverage Ratio yearly trend continues to be comparatively stable with very little volatility. Dividend Paid And Capex Coverage Ratio will likely drop to -6.55 in 2024. From the period from 2010 to 2024, Arcturus Therapeutics Dividend Paid And Capex Coverage Ratio quarterly data regression had r-value of  0.61 and coefficient of variation of (119.16). View All Fundamentals
 
Dividend Paid And Capex Coverage Ratio  
First Reported
2010-12-31
Previous Quarter
(6.24)
Current Value
(6.55)
Quarterly Volatility
110.36634118
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Arcturus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcturus Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 530 K or Selling General Administrative of 55.5 M, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 3.17. Arcturus financial statements analysis is a perfect complement when working with Arcturus Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Arcturus Therapeutics Correlation against competitors.

Latest Arcturus Therapeutics' Dividend Paid And Capex Coverage Ratio Growth Pattern

Below is the plot of the Dividend Paid And Capex Coverage Ratio of Arcturus Therapeutics Holdings over the last few years. It is Arcturus Therapeutics' Dividend Paid And Capex Coverage Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcturus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Dividend Paid And Capex Coverage Ratio10 Years Trend
Slightly volatile
   Dividend Paid And Capex Coverage Ratio   
       Timeline  

Arcturus Dividend Paid And Capex Coverage Ratio Regression Statistics

Arithmetic Mean(92.62)
Geometric Mean34.31
Coefficient Of Variation(119.16)
Mean Deviation85.91
Median(39.65)
Standard Deviation110.37
Sample Variance12,181
Range363
R-Value0.61
Mean Square Error8,301
R-Squared0.37
Significance0.02
Slope14.95
Total Sum of Squares170,530

Arcturus Dividend Paid And Capex Coverage Ratio History

2024 -6.55
2023 -6.24
2022 4.14
2021 -39.65
2020 -24.6
2019 -7.88
2018 -14.05

About Arcturus Therapeutics Financial Statements

Arcturus Therapeutics shareholders use historical fundamental indicators, such as Dividend Paid And Capex Coverage Ratio, to determine how well the company is positioned to perform in the future. Although Arcturus Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Arcturus Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcturus Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Dividend Paid And Capex Coverage Ratio(6.24)(6.55)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcturus Stock Analysis

When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.